nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC16A1—Methotrexate—bone cancer	0.667	1	CbGbCtD
Gamma Hydroxybutyric Acid—Pain in extremity—Doxorubicin—bone cancer	0.000925	0.00278	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Cisplatin—bone cancer	0.000925	0.00278	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Epirubicin—bone cancer	0.000913	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Cisplatin—bone cancer	0.000912	0.00274	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000901	0.0027	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Epirubicin—bone cancer	0.000894	0.00268	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Epirubicin—bone cancer	0.000882	0.00265	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000882	0.00265	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000872	0.00262	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal distension—Epirubicin—bone cancer	0.00087	0.00261	CcSEcCtD
Gamma Hydroxybutyric Acid—Ataxia—Doxorubicin—bone cancer	0.00087	0.00261	CcSEcCtD
Gamma Hydroxybutyric Acid—Blood creatinine increased—Doxorubicin—bone cancer	0.000867	0.0026	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Epirubicin—bone cancer	0.000864	0.00259	CcSEcCtD
Gamma Hydroxybutyric Acid—Dehydration—Doxorubicin—bone cancer	0.000861	0.00258	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Cisplatin—bone cancer	0.00086	0.00258	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Cisplatin—bone cancer	0.000853	0.00256	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain upper—Doxorubicin—bone cancer	0.000845	0.00254	CcSEcCtD
Gamma Hydroxybutyric Acid—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000833	0.0025	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Cisplatin—bone cancer	0.000832	0.0025	CcSEcCtD
Gamma Hydroxybutyric Acid—Nasopharyngitis—Doxorubicin—bone cancer	0.000828	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Cisplatin—bone cancer	0.000826	0.00248	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Methotrexate—bone cancer	0.000824	0.00247	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Methotrexate—bone cancer	0.000824	0.00247	CcSEcCtD
Gamma Hydroxybutyric Acid—Depression—Methotrexate—bone cancer	0.000821	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Cisplatin—bone cancer	0.000819	0.00246	CcSEcCtD
Gamma Hydroxybutyric Acid—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000816	0.00245	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscular weakness—Doxorubicin—bone cancer	0.000816	0.00245	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal distension—Doxorubicin—bone cancer	0.000805	0.00242	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Methotrexate—bone cancer	0.000803	0.00241	CcSEcCtD
Gamma Hydroxybutyric Acid—Influenza—Doxorubicin—bone cancer	0.0008	0.0024	CcSEcCtD
Gamma Hydroxybutyric Acid—Pollakiuria—Epirubicin—bone cancer	0.000799	0.0024	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Cisplatin—bone cancer	0.000789	0.00237	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Epirubicin—bone cancer	0.000787	0.00236	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Methotrexate—bone cancer	0.000785	0.00236	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Epirubicin—bone cancer	0.000782	0.00235	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Epirubicin—bone cancer	0.00078	0.00234	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Methotrexate—bone cancer	0.000777	0.00233	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Epirubicin—bone cancer	0.000771	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Epirubicin—bone cancer	0.000771	0.00231	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Epirubicin—bone cancer	0.000751	0.00225	CcSEcCtD
Gamma Hydroxybutyric Acid—Pollakiuria—Doxorubicin—bone cancer	0.000739	0.00222	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Epirubicin—bone cancer	0.000735	0.00221	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Methotrexate—bone cancer	0.000734	0.0022	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Methotrexate—bone cancer	0.00073	0.00219	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight increased—Doxorubicin—bone cancer	0.000728	0.00218	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Epirubicin—bone cancer	0.000727	0.00218	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Methotrexate—bone cancer	0.000725	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Weight decreased—Doxorubicin—bone cancer	0.000724	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Epirubicin—bone cancer	0.000723	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperglycaemia—Doxorubicin—bone cancer	0.000722	0.00217	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation NOS—Doxorubicin—bone cancer	0.000713	0.00214	CcSEcCtD
Gamma Hydroxybutyric Acid—Infestation—Doxorubicin—bone cancer	0.000713	0.00214	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Cisplatin—bone cancer	0.000705	0.00212	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Doxorubicin—bone cancer	0.000695	0.00209	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Epirubicin—bone cancer	0.000694	0.00208	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Methotrexate—bone cancer	0.000691	0.00207	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Methotrexate—bone cancer	0.000689	0.00207	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Epirubicin—bone cancer	0.000688	0.00207	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Cisplatin—bone cancer	0.000687	0.00206	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Epirubicin—bone cancer	0.000687	0.00206	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Methotrexate—bone cancer	0.000686	0.00206	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Epirubicin—bone cancer	0.000683	0.00205	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Epirubicin—bone cancer	0.000682	0.00205	CcSEcCtD
Gamma Hydroxybutyric Acid—Haematuria—Doxorubicin—bone cancer	0.00068	0.00204	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Epirubicin—bone cancer	0.00068	0.00204	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Epirubicin—bone cancer	0.000678	0.00204	CcSEcCtD
Gamma Hydroxybutyric Acid—Epistaxis—Doxorubicin—bone cancer	0.000673	0.00202	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Methotrexate—bone cancer	0.000671	0.00201	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Doxorubicin—bone cancer	0.000669	0.00201	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Methotrexate—bone cancer	0.000668	0.002	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Methotrexate—bone cancer	0.000666	0.002	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Methotrexate—bone cancer	0.000663	0.00199	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Cisplatin—bone cancer	0.000655	0.00197	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Methotrexate—bone cancer	0.000653	0.00196	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Methotrexate—bone cancer	0.000648	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Epirubicin—bone cancer	0.000647	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Epirubicin—bone cancer	0.000645	0.00194	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Methotrexate—bone cancer	0.000644	0.00193	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Epirubicin—bone cancer	0.000642	0.00193	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Doxorubicin—bone cancer	0.000642	0.00193	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Doxorubicin—bone cancer	0.000637	0.00191	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Doxorubicin—bone cancer	0.000635	0.00191	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Doxorubicin—bone cancer	0.000632	0.0019	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Doxorubicin—bone cancer	0.000631	0.00189	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Methotrexate—bone cancer	0.00063	0.00189	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Doxorubicin—bone cancer	0.000629	0.00189	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Epirubicin—bone cancer	0.000628	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Doxorubicin—bone cancer	0.000628	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Epirubicin—bone cancer	0.000625	0.00188	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Epirubicin—bone cancer	0.000624	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Methotrexate—bone cancer	0.000623	0.00187	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Epirubicin—bone cancer	0.000621	0.00186	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Epirubicin—bone cancer	0.000611	0.00183	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Cisplatin—bone cancer	0.000609	0.00183	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Methotrexate—bone cancer	0.000607	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Epirubicin—bone cancer	0.000606	0.00182	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Cisplatin—bone cancer	0.000604	0.00181	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Cisplatin—bone cancer	0.000603	0.00181	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Epirubicin—bone cancer	0.000602	0.00181	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Doxorubicin—bone cancer	0.000598	0.0018	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Doxorubicin—bone cancer	0.000597	0.00179	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Methotrexate—bone cancer	0.000595	0.00179	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Doxorubicin—bone cancer	0.000594	0.00178	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Epirubicin—bone cancer	0.000591	0.00177	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Epirubicin—bone cancer	0.00059	0.00177	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Epirubicin—bone cancer	0.000585	0.00176	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Epirubicin—bone cancer	0.000583	0.00175	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Doxorubicin—bone cancer	0.000581	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Epirubicin—bone cancer	0.000579	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Doxorubicin—bone cancer	0.000578	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Methotrexate—bone cancer	0.000578	0.00174	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Doxorubicin—bone cancer	0.000577	0.00173	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Doxorubicin—bone cancer	0.000574	0.00172	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Cisplatin—bone cancer	0.000569	0.00171	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Epirubicin—bone cancer	0.000568	0.0017	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Doxorubicin—bone cancer	0.000566	0.0017	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Doxorubicin—bone cancer	0.000561	0.00168	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Methotrexate—bone cancer	0.000558	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Doxorubicin—bone cancer	0.000557	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Epirubicin—bone cancer	0.000557	0.00167	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Epirubicin—bone cancer	0.000554	0.00166	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Methotrexate—bone cancer	0.000548	0.00164	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Methotrexate—bone cancer	0.000548	0.00164	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Methotrexate—bone cancer	0.000548	0.00164	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Doxorubicin—bone cancer	0.000547	0.00164	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Doxorubicin—bone cancer	0.000546	0.00164	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000544	0.00163	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Doxorubicin—bone cancer	0.000541	0.00162	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Epirubicin—bone cancer	0.000541	0.00162	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Epirubicin—bone cancer	0.00054	0.00162	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Doxorubicin—bone cancer	0.000539	0.00162	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Doxorubicin—bone cancer	0.000536	0.00161	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Epirubicin—bone cancer	0.000532	0.0016	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Methotrexate—bone cancer	0.00053	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Epirubicin—bone cancer	0.000529	0.00159	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Doxorubicin—bone cancer	0.000525	0.00158	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Epirubicin—bone cancer	0.000522	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Methotrexate—bone cancer	0.000522	0.00157	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Epirubicin—bone cancer	0.00052	0.00156	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Methotrexate—bone cancer	0.000515	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Doxorubicin—bone cancer	0.000515	0.00155	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Epirubicin—bone cancer	0.000513	0.00154	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Epirubicin—bone cancer	0.000513	0.00154	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Epirubicin—bone cancer	0.000513	0.00154	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Doxorubicin—bone cancer	0.000512	0.00154	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Epirubicin—bone cancer	0.000511	0.00153	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Methotrexate—bone cancer	0.00051	0.00153	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000509	0.00153	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Methotrexate—bone cancer	0.000508	0.00152	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Epirubicin—bone cancer	0.000502	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Doxorubicin—bone cancer	0.000501	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Methotrexate—bone cancer	0.000501	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Doxorubicin—bone cancer	0.0005	0.0015	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Epirubicin—bone cancer	0.000496	0.00149	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Doxorubicin—bone cancer	0.000492	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Epirubicin—bone cancer	0.000492	0.00148	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Doxorubicin—bone cancer	0.00049	0.00147	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Epirubicin—bone cancer	0.000488	0.00147	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Epirubicin—bone cancer	0.000484	0.00145	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Doxorubicin—bone cancer	0.000483	0.00145	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Epirubicin—bone cancer	0.000482	0.00145	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Doxorubicin—bone cancer	0.000481	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000479	0.00144	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Epirubicin—bone cancer	0.000477	0.00143	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Epirubicin—bone cancer	0.000475	0.00143	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Methotrexate—bone cancer	0.000475	0.00143	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Doxorubicin—bone cancer	0.000474	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Doxorubicin—bone cancer	0.000474	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Doxorubicin—bone cancer	0.000474	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Doxorubicin—bone cancer	0.000473	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Methotrexate—bone cancer	0.000472	0.00142	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000471	0.00141	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Epirubicin—bone cancer	0.000469	0.00141	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Methotrexate—bone cancer	0.000468	0.00141	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Methotrexate—bone cancer	0.000467	0.0014	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Doxorubicin—bone cancer	0.000464	0.00139	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Methotrexate—bone cancer	0.000462	0.00139	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Doxorubicin—bone cancer	0.000459	0.00138	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Methotrexate—bone cancer	0.000457	0.00137	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Doxorubicin—bone cancer	0.000455	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Methotrexate—bone cancer	0.000453	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Methotrexate—bone cancer	0.000453	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Doxorubicin—bone cancer	0.000452	0.00136	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Methotrexate—bone cancer	0.000449	0.00135	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000448	0.00134	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Doxorubicin—bone cancer	0.000447	0.00134	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Doxorubicin—bone cancer	0.000446	0.00134	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Epirubicin—bone cancer	0.000445	0.00133	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Doxorubicin—bone cancer	0.000442	0.00133	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Epirubicin—bone cancer	0.000441	0.00132	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Doxorubicin—bone cancer	0.00044	0.00132	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Epirubicin—bone cancer	0.000438	0.00132	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Epirubicin—bone cancer	0.000437	0.00131	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Doxorubicin—bone cancer	0.000434	0.0013	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Methotrexate—bone cancer	0.000433	0.0013	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Epirubicin—bone cancer	0.000433	0.0013	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Methotrexate—bone cancer	0.00043	0.00129	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Epirubicin—bone cancer	0.000427	0.00128	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Epirubicin—bone cancer	0.000424	0.00127	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Epirubicin—bone cancer	0.000424	0.00127	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Epirubicin—bone cancer	0.00042	0.00126	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Epirubicin—bone cancer	0.00042	0.00126	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Methotrexate—bone cancer	0.000417	0.00125	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Methotrexate—bone cancer	0.000415	0.00125	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000414	0.00124	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Doxorubicin—bone cancer	0.000411	0.00123	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Doxorubicin—bone cancer	0.000408	0.00123	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Doxorubicin—bone cancer	0.000406	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Epirubicin—bone cancer	0.000405	0.00122	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Doxorubicin—bone cancer	0.000404	0.00121	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Epirubicin—bone cancer	0.000402	0.00121	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Doxorubicin—bone cancer	0.0004	0.0012	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Doxorubicin—bone cancer	0.000395	0.00119	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000393	0.00118	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Doxorubicin—bone cancer	0.000392	0.00118	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Epirubicin—bone cancer	0.000391	0.00117	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Doxorubicin—bone cancer	0.000389	0.00117	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Doxorubicin—bone cancer	0.000389	0.00117	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Epirubicin—bone cancer	0.000389	0.00117	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Methotrexate—bone cancer	0.000387	0.00116	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Methotrexate—bone cancer	0.000377	0.00113	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Doxorubicin—bone cancer	0.000375	0.00112	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Doxorubicin—bone cancer	0.000372	0.00112	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Epirubicin—bone cancer	0.000362	0.00109	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Doxorubicin—bone cancer	0.000361	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Doxorubicin—bone cancer	0.00036	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Methotrexate—bone cancer	0.000359	0.00108	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Epirubicin—bone cancer	0.000353	0.00106	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Methotrexate—bone cancer	0.000347	0.00104	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Epirubicin—bone cancer	0.000336	0.00101	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Doxorubicin—bone cancer	0.000335	0.00101	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Methotrexate—bone cancer	0.000334	0.001	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Methotrexate—bone cancer	0.000331	0.000994	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Methotrexate—bone cancer	0.000331	0.000993	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Methotrexate—bone cancer	0.000329	0.000987	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Doxorubicin—bone cancer	0.000326	0.000979	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Epirubicin—bone cancer	0.000325	0.000975	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Epirubicin—bone cancer	0.000313	0.000938	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Methotrexate—bone cancer	0.000312	0.000936	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Doxorubicin—bone cancer	0.000311	0.000934	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Epirubicin—bone cancer	0.00031	0.00093	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Epirubicin—bone cancer	0.00031	0.000929	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Epirubicin—bone cancer	0.000308	0.000924	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Doxorubicin—bone cancer	0.000301	0.000903	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Epirubicin—bone cancer	0.000292	0.000876	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Doxorubicin—bone cancer	0.000289	0.000868	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Doxorubicin—bone cancer	0.000287	0.000861	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Doxorubicin—bone cancer	0.000287	0.00086	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Doxorubicin—bone cancer	0.000285	0.000855	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Doxorubicin—bone cancer	0.00027	0.000811	CcSEcCtD
